Arizona State University Awarded $7.4 Million NIH Grant to Research Plant-Based Microbicides
August 18, 2004
Arizona State University
has received a $7.4 million NIH grant for research on microbicides to prevent the sexual transmission of HIV, the Arizona Republic reports (Fehr-Snyder, Arizona Republic, 8/17). Microbicides include a range of products such as gels, films, sponges and other products that could help prevent the sexual transmission of HIV and other sexually transmitted diseases. Although HIV is transmitted primarily through heterosexual intercourse in much of Africa and Asia, no female-controlled HIV prevention method currently is widely available. An effective microbicide would be important for women in resource-poor countries whose partners refuse to use condoms (Kaiser Daily HIV/AIDS Report, 7/16). The Arizona State researchers will be working with the Center for Vaccine Development at the University of Maryland-Baltimore and San Diego-based Mapp Biopharmaceutical to modify the genetic code of tobacco plants to produce a protein that would prevent the transmission of HIV and other STDs, according to the Republic. Although the group also will conduct research on corn plants, Mapp CEO Kevin Whaley said that the group "prefers" using tobacco because the plant "has a lot of genetic information that is known" and it is not a food source, according to the Republic. The researchers hope to make a microbicide gel using a protein extracted from tobacco that could prevent STD transmission and be an effective contraceptive method. Charlie Arntzen, director of the Center for Infectious Diseases and Vaccinology at Arizona State University's Biodesign Institute, said, "If microbicides are going to get beyond a wish list sort of thing, they're going to have to be much more affordable and easy to produce in great quantities" (Arizona Republic, 8/17).
Microbicide "Critical Front" in Fighting AIDS
Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2004 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Declines in Cincinnati's Chlamydia, Gonorrhea Prevalence "Encouraging but Difficult to Explain," Public Health Officials Say
HIV/AIDS Growing "Beyond Tight Circles" of Injection Drug Users in Russia, Christian Science Monitor Reports
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.